ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,163.81
-0.90%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) 뉴스

XRTX XORTX Therapeutics Inc

2.93
0.34 (13.13%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
XORTX Therapeutics Inc XRTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.34 13.13% 2.93 05:59:59
개장가 저가 고가 종가 전일 종가
2.75 2.5301 3.00 2.93 2.59
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/04/202420:00GLOBEXORTX Announces Publication of Key Research in ADPKD
08/04/202420:30GLOBEXORTX Welcomes New Member to the Board of Directors
08/04/202420:00GLOBEXORTX Announces Participation in Spring 2024 Investor..
27/03/202418:00GLOBEXORTX Announces New Clinical Advisory Board Member
19/03/202418:00GLOBEXORTX Highlights Achievements of 2023 and Preparation for..
11/03/202420:00GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
04/03/202421:00GLOBEXORTX Finalizes $2.7 Million Prospectus Supplement and..
15/02/202421:00GLOBEXORTX Raises $2.5 Million Under Prospectus Supplement and..
02/02/202410:46GLOBEXORTX Files an Amended and Restated Prospectus Supplement..
15/01/202421:00GLOBEXORTX Announces $2 Million Public Offering
03/01/202421:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/01/202421:00GLOBEXORTX Submits a New Patent for the Treatment of Chronic..
02/01/202422:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/01/202421:00GLOBEXORTX Welcomes New Member to the Board of Directors
01/12/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202321:30GLOBEXORTX Announces US ATM Offering
30/11/202311:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202321:00GLOBEXORTX Meets Nasdaq Continued Listing Requirements
13/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/11/202321:00GLOBEXORTX Clarifies Timing for Share Consolidation
09/11/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202307:00GLOBEXORTX Announces Share Consolidation
02/11/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202320:00GLOBEXORTX Sponsored Study Presented at the American Society of..
28/10/202306:30GLOBEXORTX Announces Results of Special Meeting of Shareholders
26/10/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202306:00GLOBEXORTX Announces Date for Rescheduled Special Meeting of..
25/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202320:00GLOBEXORTX Announces Rescheduling of Special Meeting of..
12/10/202320:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/10/202320:00GLOBEXORTX Reports that Independent Proxy Firm, ISS, Recommends..
05/10/202302:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202320:00GLOBEXORTX Calls Special Meeting of Shareholders
28/09/202320:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/09/202320:00GLOBEXORTX Sponsored Study Selected for Presentation at the..
13/09/202304:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202320:00GLOBEXORTX Announces Participation at Upcoming Investor..
07/09/202321:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/09/202320:00GLOBEXORTX Joins the Kidney Foundation and Kidney March
29/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202320:00GLOBEXORTX Submits Orphan Drug Designation Application to the..
25/08/202319:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/08/202305:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/08/202305:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
05/08/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/08/202306:00GLOBEXORTX Appoints Chief Financial Officer

최근 히스토리

NASDAQ
XRTX
XORTX Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유